You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Canagliflozin

Showing 1 - 25 of 203
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in Hangzhou (Canagliflozin and Gemcitabine, Gemcitabine)

Not yet recruiting
  • Pancreatic Cancer
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Jun 11, 2023

Healthy Volunteers Trial run by the NIDDK (Placebo, Canagliflozin)

Completed
  • Healthy Volunteers
  • Placebo
  • Canagliflozin
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Type 2 Diabetes Trial in Nanjing (Mulberry Twig Alkaloid Tablet, Canagliflozin)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Mulberry Twig Alkaloid Tablet
  • Canagliflozin
  • Nanjing, China
    Jianhua Ma
May 3, 2023

Chronic Heart Failure, Acute Decompensated Heart Failure, Diabetes Trial in Giza (Canagliflozin)

Recruiting
  • Chronic Heart Failure
  • +2 more
  • Giza, Egypt
    National heart institute
Oct 11, 2022

Diabetes, Type 2 Trial in Decatur (canagliflozin, )

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • canagliflozin
  • placebo
  • Decatur, Georgia
    Atlanta VA Medical Center
Aug 12, 2022

Diabetes Type 2, Coronary Artery Disease Trial (Canagliflozin, Placebo)

Not yet recruiting
  • Diabetes Type 2
  • Coronary Artery Disease
  • Canagliflozin
  • Placebo
  • (no location specified)
Jun 16, 2022

Type 2 Diabetes With Complication Trial in Xi'an (Canagliflozin, Pioglitazone)

Recruiting
  • Type 2 Diabetes Mellitus With Complication
  • Xi'an, Shannxi, China
    First Affiliated Hospital Xi'an Jiaotong University
Aug 22, 2022

Type 2 Diabetes With Complication Trial (Canagliflozin, Pioglitazone)

Not yet recruiting
  • Type 2 Diabetes Mellitus With Complication
  • (no location specified)
Jul 5, 2022

ESRD, CKD Stage 4, CKD Stage 5 Trial in Montreal (Invokana 300 mg and 100 mg tablet)

Not yet recruiting
  • ESRD
  • +2 more
  • Invokana 300 mg and 100 mg tablet
  • Montreal, Quebec, Canada
    McGill University Health Center Research Institute
Mar 24, 2022

Type 2 Diabetes, Cardiovascular Diseases, Cardiac Perfusion Defect Trial in Shanghai (Canagliflozin 100mg or Sitagliptin 100mg)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • Canagliflozin 100mg or Sitagliptin 100mg
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
May 4, 2022

PreDiabetes, Hiv Trial in Shanghai (Canagliflozin, Placebo)

Recruiting
  • PreDiabetes
  • Hiv
  • Canagliflozin
  • Placebo
  • Shanghai, Shanghai, China
    Intervention Effect of Canagliflozin on Prediabetes in Patients
Feb 19, 2022

Diabetes Trial in India (Canagliflozin + Metformin HCl (Fixed Dose Combination))

Completed
  • Diabetes Mellitus
  • Canagliflozin + Metformin hydrochloride (Fixed Dose Combination)
  • Bengaluru, India
  • +9 more
Aug 16, 2022

Diabetes, Type 2 Trial (Canagliflozin)

Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • Canagliflozin
  • (no location specified)
Dec 7, 2021

Heart Failure Trial in United States (Canagliflozin 100 mg, Placebo)

Completed
Has Results
  • Heart Failure
  • Canagliflozin 100 mg
  • Placebo
  • Fort Smith, Arkansas
  • +17 more
Dec 20, 2022

Polycystic Ovary Syndrome Trial in Shenyang (Canagliflozin combined with metformin, metformin)

Completed
  • Polycystic Ovary Syndrome
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Apr 13, 2022

Type 1 Diabetes Trial in New Haven (canagliflozin, basal interruption without canagliflozin)

Completed
Has Results
  • Type 1 Diabetes
  • canagliflozin
  • basal interruption without canagliflozin
  • New Haven, Connecticut
    Yale University School of Medicine
Sep 17, 2021

Harmonizing RCT-Duplicate Emulations In A Real World Replication

Completed
  • Type 2 Diabetes Mellitus
  • Canagliflozin
  • +4 more
  • Gothenburg, Sweden
    Research Site
Oct 23, 2023

Fatty Liver Disease Trial in Tainan (Canagliflozin 100mg)

Completed
  • Fatty Liver Disease
  • Canagliflozin 100mg
  • Tainan, Taiwan
    National Cheng Kung University Hospital
Feb 28, 2023

Cognitive Protective Effect of Newer Antidiabetic Drugs

Recruiting
  • Type 2 Diabetes
  • Alexandria, Egypt
    Alexandria University
Jul 24, 2022

Type 2 Diabetes, Diabetic Kidney Disease Trial in Aurora, Boston, Ann Arbor (canagliflozin, Aminohippurate Sodium Inj 20%)

Recruiting
  • Type 2 Diabetes
  • Diabetic Kidney Disease
  • canagliflozin
  • Aminohippurate Sodium Inj 20%
  • Aurora, Colorado
  • +3 more
Aug 17, 2022

Diabetic Nephropathy Trial in Japan (Canagliflozin, Placebo)

Completed
  • Diabetic Nephropathy
  • Canagliflozin
  • Placebo
  • Aichi, Japan
  • +25 more
Sep 2, 2021

SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.

Recruiting
  • Coronary Artery Disease
  • Diabete Mellitus
  • SGLT2 inhibitor
  • Beijing, Beijing, China
    Beijing Anzhen Hospital
Apr 12, 2022

Postprandial Hypoglycemia Trial in Barcelona (Canagliflozin 300 MG Oral Tablet)

Unknown status
  • Postprandial Hypoglycemia
  • Canagliflozin 300 MG Oral Tablet
  • Barcelona, Spain
    Andreea Ciudin
Jan 26, 2021

Type II Diabetes in Subjects BMI 27 to 32 Trial in Singapore (Roux-en-Y Gastric Bypass (RYGB), Incretin analogues, Xenical)

Completed
  • Type II Diabetes in Subjects BMI 27 to 32
  • Roux-en-Y Gastric Bypass (RYGB)
  • +4 more
  • Singapore, Singapore
    Khoo Teck Puat Hospital
Jun 22, 2022

Diabetes, Type 2, Obesity Trial in Cleveland (canagliflozin, Placebo (for canagliflozin))

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Obesity
  • canagliflozin
  • Placebo (for canagliflozin)
  • Cleveland, Ohio
    Cleveland Clinic
Oct 23, 2020